½ÃÀ庸°í¼­
»óǰÄÚµå
1722629

ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀå º¸°í¼­ : ¼ººÐ, À¯Åë ä³Î, ¿ëµµ, ÇüÅÂ, Áö¿ªº°(2025-2033³â)

Probiotics Market Report by Ingredient, Distribution Channel, Application, Form, and Region 2025-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 145 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀå ±Ô¸ð´Â 2024³â 676¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö ½ÃÀå ±Ô¸ð°¡ 1,206¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, 2025-2033³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 6.3%¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ¼ÒÈ­±â ÁúȯÀÇ Áõ°¡, ±â´É¼º ½Äǰ ¹× À½¿ë ½ÄǰÀÇ ¼Òºñ È®´ë, ÀǾàǰ °³¹ßÀÇ È®´ë°¡ ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀå ºÐ¼®:

ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀμÒÈ­±â ÁúȯÀÇ Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °Ç°­°ú À£ºù¿¡ ´ëÇÑ °³ÀÎÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ : °í·ÉÈ­ Àα¸ÀÇ Áõ°¡´Â Àå °Ç°­°ú ¸é¿ª ±â´ÉÀ» Çâ»ó½ÃŰ´Â ÇÁ·Î¹ÙÀÌ¿Àƽ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó ½ÃÀå Àü¸ÁÀº ¾çÈ£ÇÕ´Ï´Ù. ¶ÇÇÑ, ±â´É¼º ½Äǰ ¹× À½·áÀÇ ¼Òºñ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Áö¸®Àû µ¿Çâ : ¾Æ½Ã¾ÆÅÂÆò¾çÀº °í·ÉÈ­¿Í ÇÔ²² ¼ÒÈ­±â ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °¡Àå Å« ºÎ¹®À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

°æÀï ȯ°æ : ÇÁ·Î¹ÙÀÌ¿Àƽ½º »ê¾÷ÀÇ ÁÖ¿ä ½ÃÀå ±â¾÷Àº Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestle S.A., PepsiCo Inc, Probi (Symrise AG), Yakult Honsha Co.Ltd. µîÀÌ ÀÖ½À´Ï´Ù.

µµÀü°ú ±âȸ : ½ÃÀåÀº ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀåÀÇ ¼öÀͰú ¼ö±Þ ºÒ±ÕÇü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Ä¡¿­ÇÑ °æÀï°ú ½ÃÀå Æ÷È­¶ó´Â µµÀü¿¡ Á÷¸éÇÑ ¹Ý¸é, ÁÖ¿ä ±â¾÷µéÀÌ ÇÁ·Î¹ÙÀÌ¿Àƽ½º¸¦ º¸´Ù È¿À²ÀûÀÌ°í ´ë·®À¸·Î »ý»êÇÒ ¼ö ÀÖ´Â »ý»ê ±â¼úÀ» °³¹ßÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ ¸ÂÀÌÇϰí ÀÖ½À´Ï´Ù.

ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀå µ¿Çâ:

±â´É¼º ½Äǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

IMARC GroupÀÇ º¸°í¼­¿¡ µû¸£¸é, ¼¼°è ±â´É¼º ½Äǰ ½ÃÀå ±Ô¸ð´Â 2023³â 2,211¾ï ´Þ·¯¿¡ ´ÞÇßÀ¸¸ç, 2032³â¿¡´Â 3,689¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀåÀÇ Áß¿äÇÑ ÃËÁø¿äÀÎ Áß Çϳª´Â ±â´É¼º ½Äǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ¼ÒºñÀÚµéÀº ¿µ¾ç°ú ´õºÒ¾î °Ç°­»óÀÇ ÀÌÁ¡À» Á¦°øÇÒ ¼ö ÀÖ´Â À½·á ¹× ½Äǰ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÇÁ·Î¹ÙÀÌ¿Àƽ½º ÇÔÀ¯ Á¦Ç°À» Æ÷ÇÔÇÑ ±â´É¼º ½ÄǰÀº ½Åü ±â´ÉÀ» Áö¿øÇϰí Áúº´À» ¿¹¹æÇÏ´Â Áß¿äÇÑ °ø±Þ¿øÀ¸·Î ¿©°ÜÁö°í ÀÖ½À´Ï´Ù. µÑ°, Àå °Ç°­ÀÇ Á߿伺¿¡ ´ëÇÑ °³ÀÎÀÇ °Ç°­ Àǽİú ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·¯ÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. »ç¶÷µéÀº Àå³» ¼¼±ÕÃÑÀÌ Àü¹ÝÀûÀÎ °Ç°­ »óÅ¿¡ ¹ÌÄ¡´Â ¿ªÇÒ¿¡ ´ëÇÑ Áö½ÄÀÌ ³ô¾ÆÁö¸é¼­ ¼ÒÈ­±â°ü¿¡ µµ¿òÀÌ µÇ´Â Á¦Ç°À» ±¸¸ÅÇϰíÀÚ ÇÏ´Â ¿­¸ÁÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù. ÇÁ·Î¹ÙÀÌ¿Àƽ½º´Â Àå³» ¼¼±ÕÃÑÀÇ ±ÕÇüÀ» ¸ÂÃß°í Àå³» ȯ°æÀ» °³¼±Çϴ õ¿¬ Á¦Ç°À̱⠶§¹®¿¡ °Ç°­ ÁöÇâÀûÀÎ ¼ÒºñÀÚµé »çÀÌ¿¡¼­ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù.

ÀǾàǰ °³¹ß È®´ë

ÇÁ·Î¹ÙÀÌ¿Àƽ½ºÀÇ ÀÛ¿ë ±âÀü°ú Ä¡·á °¡´É¼ºÀ» ±Ô¸íÇϱâ À§ÇÑ ¿¬±¸°¡ ÁøÇàµÊ¿¡ µû¶ó, ±× È¿´ÉÀ» ÀÔÁõÇϱâ À§ÇÑ ¾çÁúÀÇ ÀÓ»ó½ÃÇèÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ½Å¾à °³¹ßÀ» À§Çؼ­´Â ÀÓ»óÀûÀ¸·Î °ËÁõµÈ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ±ÕÁÖÀÇ Æ¯Á¤ °Ç°­ »óŸ¦ Ä¡·áÇÏ´Â µ¥ ÀÖ¾î ¾ÈÀü¼º°ú È¿´ÉÀ» ÀÔÁõÇÏ´Â ¹«ÀÛÀ§ ´ëÁ¶ ½ÃÇèÀ» ½Ç½ÃÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀÓ»ó½ÃÇèÀº ÇÁ·Î¹ÙÀÌ¿Àƽ½ºÀÇ Ä¡·áÁ¦·Î¼­ÀÇ »ç¿ëÀ» µÞ¹ÞħÇÏ´Â °úÇÐÀû Áõ°Å¸¦ »ý¼ºÇÏ¿© ¼ÒºñÀÚÀÇ ½Å·Ú¸¦ ³ôÀ̰í ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷µéÀº ÇÁ·Î¹ÙÀÌ¿Àƽ½º ÀǾàǰ °³¹ß¿¡ ÅõÀÚÇÏ´Â ÇÑÆí, »õ·Î¿î ÇÁ·Î¹ÙÀÌ¿Àƽ½º ±ÕÁÖ, Á¦Çü ¹× Ä¡·á ¿ëµµ¿¡ ´ëÇÑ Æ¯Çã º¸È£¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤ºÎ ±â°üÀº Á¦Á¦ÀÇ ¾ÈÀü¼º°ú ¾ÈÁ¤¼ºÀ» Áß¿ä½ÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°èÀûÀ¸·Î ÀǾàǰ °³¹ß ¹× Ç×»ýÁ¦ Á¦Á¶¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ º¸°Çº¹ÁöºÎ´Â 2022³â±îÁö 4,000¸¸ ´Þ·¯¸¦ ÅõÀÚÇÏ¿© Ȱ¼º Á¦¾à ¼ººÐ(API) ¹× Ç×»ýÁ¦ ¹ÙÀÌ¿À Á¦Á¶ÀÇ ¿ªÇÒÀ» È®´ëÇÒ °èȹÀÔ´Ï´Ù.

µ¿¹° »ç·á »ê¾÷ÀÇ ¹ø¿µ

IMARC GroupÀÇ º¸°í¼­¿¡ µû¸£¸é, ¼¼°è µ¿¹° »ç·á ½ÃÀåÀº 2032³â±îÁö 6,747¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °¡Ãà°ú °¡±Ý·ù»Ó¸¸ ¾Æ´Ï¶ó ¹Ý·Áµ¿¹°¿¡¼­µµ µ¿¹°ÀÇ Àå³» ȯ°æÀÇ Á߿伺ÀÌ Àνĵǰí ÀÖ½À´Ï´Ù. Àΰ£°ú ¸¶Âù°¡Áö·Î Àå³» ¼¼±ÕÃÑÀº ¼ÒÈ­, ¿µ¾ç ¼·Ãë, ¸é¿ª ¹ÝÀÀ, ÀϹÝÀûÀÎ °Ç°­ »óÅ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â µî µ¿¹°ÀÇ °Ç°­À» Á¿ìÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. µû¶ó¼­ µ¿¹° »ý»êÀÚ³ª ¹Ý·Áµ¿¹° ¼ÒÀ¯ÁÖµéÀº Àå °Ç°­°ú µ¿¹°ÀÇ ¼º´É Çâ»óÀ» À§ÇØ µ¿¹° »ç·á¿¡ ÇÁ·Î¹ÙÀÌ¿Àƽ½º¸¦ »ç¿ëÇÏ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. ÇÁ·Î¹ÙÀÌ¿Àƽ½º´Â Áö¼Ó°¡´ÉÇÑ °³¹ß Á¢±Ù ¹æ½Ä°ú ´õºÒ¾î »ç·á È¿À²¼º Çâ»ó°ú ¿µ¾ç¼Ò ÀÌ¿ë·ü·Î ÀÎÇÑ À§Àå Àå¾Ö °¨¼Ò¿Íµµ °ü·ÃÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÁ·Î¹ÙÀÌ¿Àƽ½º´Â µ¿¹° »ý»ê »ýŰèÀÇ »ý»ê¼º°ú Áö¼Ó°¡´É¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ Ȱ¿ëµÉ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä ¾÷°è µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ÇÁ·Î¹ÙÀÌ¿Àƽ½º ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : ¼ººÐº°

  • ¼¼±Õ
  • È¿¸ð

Á¦7Àå ½ÃÀå ³»¿ª : À¯Åë ä³Îº°

  • ½´ÆÛ¸¶Äϰú ÇÏÀÌÆÛ¸¶ÄÏ
  • ¾à±¹/µå·°½ºÅä¾î
  • Àü¹®Á¡
  • ¿Â¶óÀÎ ½ºÅä¾î
  • ±âŸ

Á¦8Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • ½Äǰ ¹× À½·á
  • ½ÄÀ̺¸ÃæÁ¦
  • µ¿¹° »ç·á

Á¦9Àå ½ÃÀå ³»¿ª : Çüź°

  • µå¶óÀÌ
  • ¾×ü

Á¦10Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå ³»¿ª : ±¹°¡º°

Á¦11Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Biogaia AB
    • Chr. Hansen Holding A/S
    • Danone S.A.
    • General Mills Inc
    • i-Health Inc(Koninklijke DSM N.V.)
    • Kerry Group plc
    • Lallemand Inc.
    • Lifeway Foods Inc
    • Morinaga Milk Industry Co. Ltd.
    • Nestle S.A.
    • PepsiCo Inc
    • Probi(Symrise AG)
    • Yakult Honsha Co.Ltd.
ksm 25.06.02

The global probiotics market size reached USD 67.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 120.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.3% during 2025-2033. Rising digestive issues, the growing consumption of functional food and beverages, and expansion of drug development is impacting the growth of the market.

Probiotics Market Analysis:

Major Market Drivers: The rising number of digestive disorders is impelling the growth of the market. Additionally, the increasing awareness among individuals about health and wellness is bolstering the market growth.

Key Market Trends: The growing aging population is driving the demand for probiotics to improve gut health and immune function, thereby offering a favorable market outlook. In addition, an increase in consumption of functional food and beverages is stimulating the market growth.

Geographical Trends: Asia Pacific holds the largest segment because of the growing prevalence of digestive issues, along with the rising aging population.

Competitive Landscape: Some of the major market players in the probiotics industry include Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestle S.A., PepsiCo Inc, Probi (Symrise AG) and Yakult Honsha Co.Ltd., among many others.

Challenges and Opportunities: While the market faces challenges like intense competition and market saturation, which impacts probiotics market revenue and supply-demand imbalances, it also encounters opportunities in the development of production technologies that allows key players to produce probiotics more efficiently and substantially.

Probiotics Market Trends:

Growing Demand for Functional Food

According to the IMARC Group's report the global functional food market size reached US$ 221.1 Billion in 2023 and expected to reach US$ 368.9 Billion by 2032. One of the significant drivers of the probiotics market is the growing demand for functional foods. Consumers are becoming more interested in food and beverages that can provide health benefits in addition to nutrition. Functional foods, which include products with probiotics, are considered an important source to support the functions of body and prevent disease. Secondly, an increase in health consciousness and awareness among individuals about the importance of gut health is driving this demand. As people are becoming more informed about the role of gut microbiota in overall well-being, they are eager to buy products that benefit their digestive system. Probiotics are a natural product that rebalances the microbiota to improve the gut, thus gaining popularity among health-conscious consumers.

Expansion of Drug Development

Growing research to elucidate the modes of action and therapeutic potential of probiotics is leading to the growing need for conducting high-quality clinical trials to prove their efficacy. Developing a new drug entail running randomized controlled trials that demonstrate the safety and efficacy of clinically validated probiotic strains in treating specific health conditions. These clinical studies generate scientific evidence that supports the use of probiotics as therapeutic agents, thereby boosting consumer confidence and driving probiotics market growth. Moreover, key players are investing in drug development for probiotics while focusing on obtaining patent protection for novel probiotic strains, formulations, and therapeutic applications. In addition, governing agencies are emphasizing the safety and stability of formulation. They are also investing in the manufacturing of drug development and antibiotics across the globe. For example, the Department of Health and Human Services invested $ 40 million in 2022 to expand the role of biomanufacturing for active pharmaceutical ingredients (APIs) and antibiotics.

Thriving Animal Feed Industry

The IMARC Group's report shows that the global animal feed market is expected to reach US$ 674.7 Billion by 2032. Increasingly, people are becoming aware about the viability of animal gut health, not just in livestock and poultry but also in pets. As in humans, the microbiota of the gut is essential in influencing animal health by impacting digestion, nutrient uptake, immune response, and general well-being among other roles. Consequently, animal producers and pet owners are increasingly adopting the use of probiotics in animal food for gut health and overall improvement of animal performance. Probiotics are likewise associated with the reduction of gastrointestinal disorders attributable to enhanced feed efficiency and utilization of nutrients, in addition to the sustainable nature of the development approach. Also, probiotics can be utilized to enhance the productivity and sustainability of animal production ecology.

Probiotics Market Segmentation:

Breakup by Ingredient:

  • Bacteria
  • Yeast

Bacteria accounts for the majority of the market share

Bacteria have been widely researched and studied for their health benefits in relation to gut health. Bacteria like Lactobacillus and Bifidobacterium species are known for their ability to promote a healthy balance of microbiota, which is essential for digestion, nutrient absorption, and immune function. In addition, bacteria are easy to incorporate into various products like dairy products, dietary supplements, and functional foods. The well-established research is supporting the health benefits of bacterial probiotics, which is boosting the growth of the segment

Breakup by Distribution Channel:

  • Supermarkets and Hypermarkets
  • Pharmacies/Drugstores
  • Specialty Stores
  • Online Stores
  • Others

Supermarkets and hypermarkets hold the largest share of the industry

Supermarkets and hypermarkets offer a broad variety of probiotic products from different brands, providing people with ample choices to suit their preferences and needs. The convenience of these stores attracts a large number of people seeking probiotics supplements and food and beverage products. Additionally, they leverage promotional strategies like discounts, special offers, and product placements to expand sales and encourage repeat purchases. Their established distribution networks also allow efficient supply chain management, ensuring consistent availability of probiotics products across the globe.

Breakup by Application:

  • Food and Beverages
  • Dietary Supplements
  • Animal Feed

Food and beverages represent the leading market segment

The incorporation of probiotics into food and beverage products offer a convenient way for consumers to take these beneficial microorganisms into their daily diet, along with the rise in hectic working schedules of people that is encouraging the adoption of ready-to-eat (RTE) meals in which probiotics are included, such as yogurt cups, snack bars, cereal, and beverages, making it easy for people to access the health benefits of probiotics without the need for additional supplementation.

Breakup by Form:

  • Dry
  • Liquid

Liquid exhibits a clear dominance in the market

The liquid probiotics offer a convenient and easy-to-consume formats for probiotics, making them accessible to a broad range of consumers. These probiotics are available in various forms like drinks, shots, and concentrates, allowing people to incorporate them into their daily routines. Moreover, these probiotics have faster absorption rate compared to other forms. They also allow greater flexibility in formulations, enabling key players to create products with diverse probiotic stains and functional ingredients to target specific health issues.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Asia Pacific leads the market, accounting for the largest probiotics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest regional market for probiotics.

The growing awareness among the masses about the benefits of probiotics is strengthening the growth of the market across the region. Moreover, rising disposable income of people in countries like China, Japan, and South Korea are driving the demand for probiotic supplements and functional foods to improve digestive health and overall wellness. In addition, governing agencies are undertaking initiatives to promote the use of probiotics in food and beverage products, which is further bolstering the market growth in the region. Besides this, the growing understanding of the importance of preventive health with several studies showing the benefits of these products on immunity, cognitive health, and skincare, along with rising aging population, is catalyzing the probiotics demand. The State Council report of the People's Report of China 2021 shows that the total population of Chinese people on the mainland aged 60 or above has reached 264.02 million, including 190.64 million people aged 65 or above.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major probiotics companies have also been provided. Some of the major market players in the probiotics industry include Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestle S.A., PepsiCo Inc, Probi (Symrise AG) and Yakult Honsha Co.Ltd.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key players are investing in research and development (R&D) activities to identify new probiotics strains, enhance formulations technologies, and better understand the mechanisms of action and health benefits of probiotics. They are also working with research institutes and healthcare organizations to develop the probiotics products. Moreover, companies are prioritizing quality assurance and control measures to ensure stability and safety of their probiotics products. Key manufacturers are also expanding their product lines to include a broad variety of probiotic formulations targeting different consumers. For instance, in 2021, Lifeway Foods, Inc., the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, announced its new line of dairy-free probiotic oat beverage at natural products expo east.

Key Questions Answered in This Report

  • 1.What was the size of the global probiotics market in 2024?
  • 2.What is the expected growth rate of the global probiotics market during 2025-2033?
  • 3.What are the key factors driving the global probiotics market?
  • 4.What has been the impact of COVID-19 on the global probiotics market?
  • 5.What is the breakup of the global probiotics market based on the ingredient?
  • 6.What is the breakup of the global probiotics market based on the distribution channel?
  • 7.What is the breakup of the global probiotics market based on application?
  • 8.What is the breakup of the global probiotics market based on the form?
  • 9.What are the key regions in the global probiotics market?
  • 10.Who are the key players/companies in the global probiotics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Probiotics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Ingredient

  • 6.1 Bacteria
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Yeast
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Supermarkets and Hypermarkets
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pharmacies/Drugstores
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Specialty Stores
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Online Stores
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Food and Beverages
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Dietary Supplements
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Animal Feed
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Form

  • 9.1 Dry
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Liquid
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Biogaia AB
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Chr. Hansen Holding A/S
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Danone S.A.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 General Mills Inc
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 i-Health Inc (Koninklijke DSM N.V.)
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Kerry Group plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Lallemand Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Lifeway Foods Inc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Morinaga Milk Industry Co. Ltd.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Nestle S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 PepsiCo Inc
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Probi (Symrise AG)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Yakult Honsha Co.Ltd.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦